One Pill, Once A Day
AUBAGIO® (teriflunomide) is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Please see below for Important Safety Information and full Prescribing Information, including Boxed WARNING.
An Infusion Treatment
LEMTRADA is indicated for the treatment of
relapsing forms of multiple sclerosis (MS), to
include relapsing-remitting disease and active
secondary progressive disease, in adults.
Because of its safety profile, the use of
LEMTRADA should generally be reserved for
patients who have had an inadequate response to
two or more drugs indicated for the treatment of
MS.
Limitations
of Use: LEMTRADA is not recommended
for use in patients with clinically isolated
syndrome (CIS) because of its safety profile.
Please see below for Important Safety Information and full Prescribing Information, including Boxed WARNING.
Get Support and Resources for Your Patients with MS One to One®
Provide your patients with services tailored to specific Sanofi relapsing MS treatments, insurance investigation and verification, prior authorization assistance, and more. Check out the resources below for tools that healthcare providers can share with patients.
See what MS One to One can do